Mahlich Joerg, Kamae Isao
Department of Economics, University of Vienna, Oskar Morgenstern Platz 1, 1090 Vienna, Austria.
Düsseldorf Institute for Competition Economics (DICE), University of Düsseldorf, Universitätsstr. 1, 40225 Düsseldorf, Germany.
Healthcare (Basel). 2024 Sep 27;12(19):1937. doi: 10.3390/healthcare12191937.
Japan's rising health expenditure, driven by an aging population, coincides with growing demands for increased spending. Reducing smoking-related costs could alleviate the burden on the health care system. Despite efforts to promote smoking cessation, success has been limited, indicating a need for strategies beyond cessation.
Using a status quo simulation based on hospital resource data from the Japanese Ministry of Health, Labor, and Welfare, we examine the impact of heated tobacco products (HTPs) on the prevalence of four smoking-attributable diseases (chronic obstructive pulmonary disease, ischemic heart disease, stroke, and lung cancer) and the related direct health care costs. The baseline scenario assumes a 50% switch from combustible cigarettes to HTPs, with a 70% risk reduction. A sensitivity analysis was conducted to assess the effects of parameter variations.
If 50% of smokers replaced combustible tobacco products with HTPs, 12 million patients could be averted equivalent to JPY 454 billion in health care savings. Prefectures located in the north and south of Japan would benefit the most.
Considering the heterogeneous prevalence rates, a one-size-fits-all tobacco control approach is ineffective. Japan should prioritize cost-efficient measures that promote public health and economic benefits. Encouraging smokers to switch to reduced-risk products, raising awareness of health risks, and adopting a harm-based taxation model can drive positive change. Public-private partnerships can further enhance harm reduction efforts. With a combination of tax reforms, revised regulations, collaborations, and ongoing research, Japan can create a more effective and comprehensive approach to tobacco control.
在人口老龄化的推动下,日本的医疗支出不断增加,与此同时,增加支出的需求也在增长。降低与吸烟相关的成本可以减轻医疗系统的负担。尽管在努力促进戒烟,但成效有限,这表明需要采取戒烟以外的策略。
利用基于日本厚生劳动省医院资源数据的现状模拟,我们研究了加热烟草制品(HTP)对四种吸烟所致疾病(慢性阻塞性肺疾病、缺血性心脏病、中风和肺癌)的患病率以及相关直接医疗成本的影响。基线情景假设50%的吸烟者从可燃香烟转向加热烟草制品,风险降低70%。进行了敏感性分析以评估参数变化的影响。
如果50%的吸烟者用加热烟草制品替代可燃烟草制品,可避免1200万患者患病,相当于节省4540亿日元的医疗费用。日本北部和南部的县将受益最大。
考虑到患病率的异质性,一刀切的烟草控制方法是无效的。日本应优先采取具有成本效益的措施,以促进公共卫生和经济效益。鼓励吸烟者转向低风险产品、提高健康风险意识以及采用基于危害的税收模式可以推动积极变革。公私伙伴关系可以进一步加强减少危害的努力。通过税收改革、修订法规、合作以及持续研究相结合,日本可以创建一种更有效、更全面的烟草控制方法。